TXMD · TherapeuticsMD, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“The potential impact of these factors in conjunction with the uncertainty of the capital markets raises substantial doubt about our ability to continue as a going concern for the next twelve months from the issuance of these financial statements.”View the 10-Q filed May 12, 2026
3 customers — 100% of revenue (the three months ended March 31, 2026)
“For the three months ended March 31, 2026, 100% of license revenue related to Mayne Pharma, Theramex and Knight.”
Positioning
Aug 21, 2026 · 23 days to expiry · 10 contractsOpen interest by strike
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | 197.7% | 0.956 | — | — | — | — | — | 0 | |
| 48 | 48 | 120.9% | 0.595 | $0.67 | $0.20 | -0.181 | 715.8% | 39 | 41 | |
| 9 | 9 | 678.3% | 0.74 | $0.15 | — | — | — | — | 0 | |
| 0 | — | — | — | — | — | — | — | — | 0 | |
| 1 | 1 | — | — | $0.20 | — | — | — | — | 0 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.